吝啬性
发表于 2025-3-30 12:06:24
Benjamin Schwessinger,John P. Rathjentain this response and become more symptomatic. Increasing disability is usually accompanied by dyskinesias and diurnal fluctuations in performance, predominantly “wearing-off” phenomena (. and . 1977; 1976). Occasionally, patients exhibit abrupt random fluctuations: “on-off” phenomena.
Constituent
发表于 2025-3-30 16:21:17
Benjamin Schwessinger,John P. Rathjens an 8-.-aminoergoline and was synthesized by . and . (1968). It is a white slightly bitter tasting substance, which is reasonably stable at room temperature if not exposed to light. Lisuride hydrogen maleate is soluble in water or saline up to 1 mg/ml. Owing to its low effective dose, it is therefo
Hormones
发表于 2025-3-30 20:26:30
http://reply.papertrans.cn/29/2833/283221/283221_53.png
preservative
发表于 2025-3-30 22:50:34
,Update on Bromocriptine in Parkinson’s Disease,tain this response and become more symptomatic. Increasing disability is usually accompanied by dyskinesias and diurnal fluctuations in performance, predominantly “wearing-off” phenomena (. and . 1977; 1976). Occasionally, patients exhibit abrupt random fluctuations: “on-off” phenomena.
外向者
发表于 2025-3-31 01:29:35
http://reply.papertrans.cn/29/2833/283221/283221_55.png
LINE
发表于 2025-3-31 08:43:41
http://reply.papertrans.cn/29/2833/283221/283221_56.png
Liberate
发表于 2025-3-31 11:46:58
http://reply.papertrans.cn/29/2833/283221/283221_57.png
FOIL
发表于 2025-3-31 15:58:22
http://reply.papertrans.cn/29/2833/283221/283221_58.png
轿车
发表于 2025-3-31 21:28:52
http://reply.papertrans.cn/29/2833/283221/283221_59.png
认为
发表于 2025-3-31 21:59:42
,Pergolide in the Treatment of Parkinson’s Disease,Pergolide mesylate, a synthetic semiergoline, is a potent dopamine agonist which holds promise as a treatment for Parkinson’s disease. Its chemical name is (8 .)-8-[(methylthio)methyl]-6-propylergoline monomethanesulfonate; its empirical formula is C.H.N.O.S. (Fig. 1), and its molecular weight is 410.6.